Risk Factors for Short Stature in Children Born Small for Gestational Age at Full-Term

Lan Ling1, Ting Chen2, Xin-Hua Zhang3

  • 1Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Insights

Identifying risk factors for short stature in full-term small for gestational age (SGA) children is crucial. Decreased placental perfusion, chromosomal abnormalities, and short parental height are key predictors of short stature in these infants.

Area of Science:

  • Pediatrics
  • Neonatology
  • Medical Imaging

Background:

  • Short stature in children born small for gestational age (SGA) at full-term is a concern.
  • Identifying associated risk factors is essential for early intervention and improved outcomes.

Purpose of the Study:

  • To identify risk factors associated with short stature in full-term SGA infants up to 2 years of age.
  • To investigate the role of placental function and maternal health in the development of short stature.

Main Methods:

  • Retrospective study of 456 full-term SGA infants followed until 2 years of age.
  • Univariate and multivariate analyses were used to identify risk factors.
  • Intravoxel Incoherent Motion (IVIM) magnetic resonance imaging (MRI) assessed placental perfusion.

Main Results:

  • 28 out of 456 (6.1%) full-term SGA children had short stature at 2 years.
  • Decreased placental perfusion (IVIM), higher umbilical artery PI, RI, and S/D ratios were observed in short children.
  • Maternal systemic lupus erythematosus and placental chorioangioma were more frequent in the short stature group.
  • Absence of catch-up growth was noted in short children.

Conclusions:

  • Key risk factors for short stature in full-term SGA children include decreased placental perfusion (IVIM), chromosomal abnormalities, and short parental height.
  • Early identification of these factors can guide clinical management and improve growth outcomes.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.4K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
595
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.2K